V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Sort by Sort ascending 職種Sort ascending 部門国勤務地掲載日 職種Sort ascending 部門国勤務地掲載日 Supply Chain Planning and Logistics Senior SpecialistRegular, Full time Innovative Medicines Spain Zaragoza Jun 05, 2025 ...

Rund 3.300 Mitarbeitende setzen sich bei Novartis Österreich gemeinsam dafür ein, das Leben von Patientinnen und Patienten zu verlängern und zu verbessern. Willst du dabei sein? Dann denke mit uns ...

Sr. Spec. DDIT IES Cloud Engineering Regular, Full time Universal Hierarchy Node India +Alternative Locations Hyderabad (Office) Giu 05, 2025 Assoc. Dir. DDIT IES Cloud Engineering Regular, Full time ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Regulus is a clinical-stage biopharmaceutical company developing microRNA therapeutics with a focus on autosomal dominant polycystic kidney disease (ADPKD), a severe renal disease Lead asset for ADPKD ...

April 26, 2023 Today Novartis has published updated 2022 quarterly and full year segment financials reflecting transfers of Sandoz biotechnology manufacturing services to other companies’ activities ...

Novartis sodeluje z društvi bolnikov v Sloveniji in po vsem svetu, saj lahko le z medsebojnim sodelovanjem izboljšamo izide zdravljenja za bolnike in vpeljemo nove pristope k zdravljenju. Celovito ...